标题
Development of direct cardiac reprogramming for clinical applications
作者
关键词
-
出版物
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
Volume 178, Issue -, Pages 1-8
出版商
Elsevier BV
发表日期
2023-03-12
DOI
10.1016/j.yjmcc.2023.03.002
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
- (2022) Connie W. Tsao et al. CIRCULATION
- Distribution of cardiomyocyte-selective adeno-associated virus serotype 9 vectors in swine following intracoronary and intravenous infusion
- (2022) Jinliang Li et al. PHYSIOLOGICAL GENOMICS
- Single-nucleus profiling of human dilated and hypertrophic cardiomyopathy
- (2022) Mark Chaffin et al. NATURE
- TBX20 Improves Contractility and Mitochondrial Function During Direct Human Cardiac Reprogramming
- (2022) Yawen Tang et al. CIRCULATION
- Direct Reprogramming Improves Cardiac Function and Reverses Fibrosis in Chronic Myocardial Infarction
- (2022) Hidenori Tani et al. CIRCULATION
- The histone reader PHF7 cooperates with the SWI/SNF complex at cardiac super enhancers to promote direct reprogramming
- (2021) Glynnis A. Garry et al. NATURE CELL BIOLOGY
- Direct reprogramming with Sendai virus vectors repaired infarct hearts at the chronic stage
- (2021) Mari Isomi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Myocarditis With COVID-19 mRNA Vaccines
- (2021) Biykem Bozkurt et al. CIRCULATION
- Overexpression of Gata4, Mef2c, and Tbx5 Generates Induced Cardiomyocytes Via Direct Reprogramming and Rare Fusion in the Heart
- (2021) Mari Isomi et al. CIRCULATION
- Direct Reprogramming Induces Vascular Regeneration Post Muscle Ischemic Injury
- (2021) Keerat Kaur et al. MOLECULAR THERAPY
- A transcriptional switch governs fibroblast activation in heart disease
- (2021) Michael Alexanian et al. NATURE
- Direct cardiac reprogramming comes of age: Recent advance and remaining challenges
- (2021) Yifang Xie et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- In vivo reprogramming as a new approach to cardiac regenerative therapy
- (2021) Taketaro Sadahiro et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Pharmacologic therapy for engraftment arrhythmia induced by transplantation of human cardiomyocytes
- (2021) Kenta Nakamura et al. Stem Cell Reports
- Hippo Pathway Effector Tead1 Induces Cardiac Fibroblast to Cardiomyocyte Reprogramming
- (2021) Vivek P. Singh et al. Journal of the American Heart Association
- A Systematic Review and Network Meta-Analysis of Pharmacological Treatment of Heart Failure With Reduced Ejection Fraction
- (2021) Jasper Tromp et al. JACC-Heart Failure
- Single-cell reconstruction of the adult human heart during heart failure and recovery reveals the cellular landscape underlying cardiac function
- (2020) Li Wang et al. NATURE CELL BIOLOGY
- Engineering adeno-associated virus vectors for gene therapy
- (2020) Chengwen Li et al. NATURE REVIEWS GENETICS
- Down-regulation of Beclin1 promotes direct cardiac reprogramming
- (2020) Li Wang et al. Science Translational Medicine
- Soft Matrix Promotes Cardiac Reprogramming via Inhibition of YAP/TAZ and Suppression of Fibroblast Signatures
- (2020) Shota Kurotsu et al. Stem Cell Reports
- Heart failure drug treatment: the fantastic four
- (2020) Johann Bauersachs EUROPEAN HEART JOURNAL
- Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
- (2020) Gregory A. Roth et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Current Clinical Applications of In Vivo Gene Therapy with AAVs
- (2020) Jerry R. Mendell et al. MOLECULAR THERAPY
- Role of cyclooxygenase-2-mediated prostaglandin E2-prostaglandin E receptor 4 signaling in cardiac reprogramming
- (2019) Naoto Muraoka et al. Nature Communications
- Adeno-associated virus vector as a platform for gene therapy delivery
- (2019) Dan Wang et al. NATURE REVIEWS DRUG DISCOVERY
- Cardiac Reprogramming Factors Synergistically Activate Genome-wide Cardiogenic Stage-Specific Enhancers
- (2019) Hisayuki Hashimoto et al. Cell Stem Cell
- Cardiac fibrosis – A short review of causes and therapeutic strategies
- (2019) Svenja Hinderer et al. ADVANCED DRUG DELIVERY REVIEWS
- Context-Specific Transcription Factor Functions Regulate Epigenomic and Transcriptional Dynamics during Cardiac Reprogramming
- (2019) Nicole R. Stone et al. Cell Stem Cell
- Single-Cell Transcriptomic Analyses of Cell Fate Transitions during Human Cardiac Reprogramming
- (2019) Yang Zhou et al. Cell Stem Cell
- Chemical-induced cardiac reprogramming in vivo
- (2018) Chenwen Huang et al. CELL RESEARCH
- Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN
- (2018) Christian Hinderer et al. HUMAN GENE THERAPY
- Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart
- (2018) Xing Fu et al. JOURNAL OF CLINICAL INVESTIGATION
- Resident fibroblast expansion during cardiac growth and remodeling
- (2018) Malina J. Ivey et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Human embryonic stem cell–derived cardiomyocytes restore function in infarcted hearts of non-human primates
- (2018) Yen-Wen Liu et al. NATURE BIOTECHNOLOGY
- Prevalence and prognosis of ischaemic and non-ischaemic myocardial fibrosis in older adults
- (2018) Sujata M Shanbhag et al. EUROPEAN HEART JOURNAL
- Efficient in vivo direct conversion of fibroblasts into cardiomyocytes using a nanoparticle-based gene carrier
- (2018) Yujung Chang et al. BIOMATERIALS
- Redefining the identity of cardiac fibroblasts
- (2017) Michelle D. Tallquist et al. Nature Reviews Cardiology
- Molecular barriers to direct cardiac reprogramming
- (2017) Haley Vaseghi et al. Protein & Cell
- Honoring 50 Years of Clinical Heart Transplantation in Circulation
- (2017) Josef Stehlik et al. CIRCULATION
- Chemical Enhancement of In Vitro and In Vivo Direct Cardiac ReprogrammingClinical Perspective
- (2016) Tamer M. A. Mohamed et al. CIRCULATION
- Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts
- (2016) Yuji Shiba et al. NATURE
- Conversion of human fibroblasts into functional cardiomyocytes by small molecules
- (2016) Nan Cao et al. SCIENCE
- In vivocardiac reprogramming using an optimal single polycistronic construct: Figure 1
- (2015) Hong Ma et al. CARDIOVASCULAR RESEARCH
- Direct reprogramming of mouse fibroblasts into cardiomyocytes with chemical cocktails
- (2015) Yanbin Fu et al. CELL RESEARCH
- Directly Reprogrammed Human Neurons Retain Aging-Associated Transcriptomic Signatures and Reveal Age-Related Nucleocytoplasmic Defects
- (2015) Jerome Mertens et al. Cell Stem Cell
- A cost-effective and efficient reprogramming platform for large-scale production of integration-free human induced pluripotent stem cells in chemically defined culture
- (2015) Jeanette Beers et al. Scientific Reports
- MiR-133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures
- (2014) N. Muraoka et al. EMBO JOURNAL
- Electrical Integration of Human Embryonic Stem Cell-Derived Cardiomyocytes in a Guinea Pig Chronic Infarct Model
- (2014) Yuji Shiba et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- “Triplet” polycistronic vectors encoding Gata4, Mef2c, and Tbx5 enhances postinfarct ventricular functional improvement compared with singlet vectors
- (2014) Megumi Mathison et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Remodeling of the Mononuclear Phagocyte Network Underlies Chronic Inflammation and Disease Progression in Heart Failure
- (2013) Mohamed Ameen Ismahil et al. CIRCULATION RESEARCH
- Association of Fibrosis With Mortality and Sudden Cardiac Death in Patients With Nonischemic Dilated Cardiomyopathy
- (2013) Ankur Gulati et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Reprogramming of human fibroblasts toward a cardiac fate
- (2013) Y.-J. Nam et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Induction of human cardiomyocyte-like cells from fibroblasts by defined factors
- (2013) R. Wada et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In Vivo Cardiac Cellular Reprogramming Efficacy Is Enhanced by Angiogenic Preconditioning of the Infarcted Myocardium With Vascular Endothelial Growth Factor
- (2013) Megumi Mathison et al. Journal of the American Heart Association
- Direct Reprogramming of Human Fibroblasts toward a Cardiomyocyte-like State
- (2013) Ji-Dong Fu et al. Stem Cell Reports
- Induction of Cardiomyocyte-Like Cells in Infarct Hearts by Gene Transfer of Gata4, Mef2c, and Tbx5
- (2012) Kohei Inagawa et al. CIRCULATION RESEARCH
- MicroRNA-Mediated In Vitro and In Vivo Direct Reprogramming of Cardiac Fibroblasts to Cardiomyocytes
- (2012) Tilanthi M. Jayawardena et al. CIRCULATION RESEARCH
- Heart repair by reprogramming non-myocytes with cardiac transcription factors
- (2012) Kunhua Song et al. NATURE
- In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes
- (2012) Li Qian et al. NATURE
- Direct Reprogramming of Mouse Fibroblasts into Cardiac Myocytes
- (2012) Kohei Inagawa et al. Journal of Cardiovascular Translational Research
- Role of YAP/TAZ in mechanotransduction
- (2011) Sirio Dupont et al. NATURE
- Direct Reprogramming of Fibroblasts into Functional Cardiomyocytes by Defined Factors
- (2010) Masaki Ieda et al. CELL
- Human embryonic stem cell-derived cardiomyocytes engraft but do not alter cardiac remodeling after chronic infarction in rats
- (2010) S. Fernandes et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Gold nanoparticles in delivery applications☆
- (2008) P GHOSH et al. ADVANCED DRUG DELIVERY REVIEWS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now